The multifaceted role of pirfenidone and its novel targets
2010 · Fibrogenesis & Tissue Repair · 158 citations
https://doi.org/10.1186/1755-1536-3-16
A
Ana Sandoval-Rodríguez
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
113
Papers
1.8K
Citations
23
h-index
35
i10-index
Ana Sandoval-Rodríguez is an academic researcher from Universidad de Guadalajara. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver physiology and pathology & Liver Disease and Transplantation. The author has an h-index of 23, co-authored 97 publications.
ORCID: 0000-0003-1708-1495Papers by this author
worksThe Role of NRF2 in Obesity-Associated Cardiovascular Risk Factors
2022 · Antioxidants · 55 citations
https://doi.org/10.3390/antiox11020235
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
2024 · Hepatology International · 29 citations
https://doi.org/10.1007/s12072-024-10702-5
A new opportunity for N-acetylcysteine. An outline of its classic antioxidant effects and its pharmacological potential as an epigenetic modulator in liver diseases treatment
2024 · Naunyn-Schmiedeberg s Archives of Pharmacology · 12 citations
https://doi.org/10.1007/s00210-024-03539-0
H3K9me3 demethylation by JMJD2B is regulated by pirfenidone resulting in improved NASH
2024 · Scientific Reports · 6 citations
https://doi.org/10.1038/s41598-024-75458-2
Impaired muscle strength is associated with ultrastructure damage in myositis
2022 · Scientific Reports · 4 citations
https://doi.org/10.1038/s41598-022-22754-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat